The constructed diagnostic prediction model and molecular docking analysis demonstrated the potential value of genes such as MMP9, NFKBIA, NFKB1, and SRC in the diagnosis and treatment of MS. The gene discussed is NFKBIA; the disease is myeloid sarcoma.